Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus
Endocrine Connections Dec 13, 2017
Guclu M, et al. - The long-term effects of exenatide treatment was investigated on serum fasting ghrelin levels in patients with type 2 diabetes mellitus. The clinicians proposed that the effects of exenatide on weight loss could be associated with the suppression of serum fasting ghrelin levels, which was an orexigenic peptide.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
